About Jennifer Ahlstrom

Articles by Jennifer Ahlstrom

New Study Finds Potential Hazards of CRISPR Gene Editing
Jul 24, 2018
Researchers Discover Curcumin Impact in Fighting Myeloma But Note Limitations
Jul 11, 2018
$Clinical Trial: Phase 1 BCMA-CD3 Bispecific Antibody for Relapsed/Refractory Myeloma Patients image$

Clinical Trial: Phase 1 BCMA-CD3 Bispecific Antibody for Relapsed/Refractory Myeloma Patients
Jun 23, 2018
Elotuzumab, Pomalyst and Dex Show Decreased Risk of Progression in Multiple Myeloma
Jun 22, 2018
Stem Cell Transplant Still Improves Myeloma Patient Survival
Jun 19, 2018
EHA: INSIGHT Update on Multiple Myeloma
Jun 14, 2018
Raynaud's Disease and Myeloma… How to Cope
Jun 12, 2018
Daratumumab with PD-1 Inhibitor Study Discontinued for Multiple Myeloma
May 27, 2018
Clinical Trials and Compassionate Use in Multiple Myeloma
May 26, 2018
Understanding the Mutations that Cause Multiple Myeloma May Help Drive Personalized Treatment
May 11, 2018
Clinical Trials: What are Bispecific Antibodies?
May 07, 2018
Only Your Genes Will Tell
Apr 24, 2018
Manejo de la enfermedad ósea en el mieloma múltiple
Apr 05, 2018
Researchers Suggest Increased Screening of MGUS Patients to Prevent Multiple Myeloma
Apr 05, 2018
Lenalidomide Every Other Day for Myeloma Patients with Kidney Concerns?
Apr 05, 2018
Changing Careers in Midst of Myeloma…
Apr 03, 2018
Por qué soy una defensora del mieloma
Mar 22, 2018
New Drug Targeting WT1 Found to Be Effective as Post-Transplant Myeloma Therapy for High-Risk Patients
Mar 20, 2018
Clinical Trial: Four Drug Induction Before Transplant Using Monoclonal Antibody for Newly Diagnosed Myeloma
Mar 17, 2018
Mutaciones genéticas familiares relacionadas con el riesgo de mieloma múltiple
Mar 15, 2018
Spotlight on Myeloma: Multiple Myeloma Awareness Month
Mar 08, 2018
Managing Bone Disease With Multiple Myeloma
Feb 23, 2018
Clinical Trial: The MASTER Trial
Feb 22, 2018
Immune System Status May Be Why Myeloma Incidence Increases With Age
Feb 08, 2018